- Home
- AUPH vs HE Comparison
AUPH vs HE Comparison
Compare AUPH & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | HE |
|---|---|---|
| Founded | 1993 | 1891 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AUPH | HE |
|---|---|---|
| Price | $16.39 | $9.00 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | ★ $17.25 | $13.25 |
| AVG Volume (30 Days) | 725.2K | ★ 2.5M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 106.32 |
| EPS | 0.53 | ★ 0.89 |
| Revenue | $283,055,000.00 | ★ $3,086,896,000.00 |
| Revenue This Year | $17.54 | $7.00 |
| Revenue Next Year | $15.74 | $4.06 |
| P/E Ratio | $31.17 | ★ $10.06 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.92 | $8.76 |
| 52 Week High | $19.25 | $17.33 |
Technical Indicators
Market Signals| Indicator | AUPH | HE |
|---|---|---|
| Relative Strength Index (RSI) | 50.61 | 15.22 |
| Support Level | $15.65 | N/A |
| Resistance Level | $16.40 | $13.82 |
| Average True Range (ATR) | 0.42 | 0.27 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 38.89 | 12.70 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the islands of Oahu, Hawaii, Maui, Molokai, and Lanai.